SG/PUT/EDWARDS LIFESCIENCES/70/0.1/20.09.24 | Market Closed - Boerse Frankfurt Warrants 01:11:39 27/06/2024 am IST | ||
| 0.052 EUR | -14.75% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 0.053 | -13.11% |
| 25/24/25 | 0.061 | -3.17% |
| 24/24/24 | 0.063 | -14.86% |
| 21/24/21 | 0.074 | -9.76% |
| 20/24/20 | 0.082 | -8.89% |
Real-time Boerse Frankfurt Warrants
Last update June 27, 2024 at 01:11 am IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SY08S6 |
| ISIN | DE000SY08S69 |
| Date issued | 04/06/2024 |
| Strike | 70 $ |
| Maturity | 20/09/2024 (86 Days) |
| Parity | 10 : 1 |
| Emission price | 0.13 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.13 € |
|---|---|
| Lowest since issue | 0.049 € |
| Spread | 0.01 € |
| Spread % | 15.63% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.56
USD
Average target price
96.05
USD
Spread / Average Target
+4.91%
- Stock Market
- Warrants
- Warrant
